Category Archives: Uncategorized

Killing off the Ta-Tas?

Angelina Jolie’s announcement that she had had a prophylactic double mastectomy prompted a thoughtful piece on NPR today. In it, Todd Tuttle, chief of surgical oncology at the University of Minnesota, discussed the motivations underlying such decisions. The number of women choosing this extreme form of preventive medicine has risen dramatically in recent years and is also much higher in the US than in Europe, although women there have the same access to surgery and reconstruction.

One cause, he said, was that women tend to greatly exaggerate their breast cancer risk when extrapolating from genetics or family history. Why is this? The NPR piece suggests that “the ubiquitous pink-ribbon campaigns may be fueling the rise in mastectomies.” We’d like to see the evidence, but it’s a profoundly ironic notion:

Could the campaign to “Save the Ta-Tas” in fact be reducing their numbers?

In an age of super-sensitive, ever more powerful diagnostics and a culture that favors preventive medicine, it becomes increasingly important for people to actually understand abstract concepts such as risk and probability.

 

Print Friendly

Composite photography now and then

A student* linked me to The Postnational Monitor, which features composite photographs of different racial, ethnic, and cultural groups. By superimposing many images (selected by unstated criteria) and centering them on the eyes and other key facial features, they produce visual “averages”. Here’s an average German male:

 

And here’s an average Irish female:

Some of the distinctions are pretty subtle. I had to look back and forth several times to make sure the Belgian and Dutch woman were not the same image. Can you tell which is which?

Statistics can be witty. Here’s “Ras’ average ex-girlfriend:

This lovely individual is the average South African female:

And the average Han Chinese man:

This fascinates me because in the 19th century, Francis Galton (Charles Darwin’s cousin and the inventor of eugenics and linear regression) invented this technique to uncover the “true” underlying features of different groups. His methods were cruder, of course, but the technique was basically the same. Here’s the essential Boston physician:

Boston physicians

But for Galton, this was more than just visual play. He thought you could identify fundamental features of physiognomy, letting one get at the structural qualities of health and behavior. Composite photography could reveal the facial features of predisposition to disease (diathesis):

It could also be useful in crime prevention. Here are portraits of the kind of man who commits larceny (without violence):

Larcenists

Right! If you see any of these men, look for the nearest Bobbie.

Today, more sophisticated image-processing could be easily combined with DNA sampling and whole-genome analysis to find genetic correlates of these facial features. The Human Genome Project was, of course, a “composite” of a sequential sort—it comprised consensus sequences of numerous individuals to provide an image of “the” human genome. Today, much of personalized medicine relies on genomic composites of “Europeans,” “Africans,” and “Han Chinese.” Someday, similarly blurry visual portraits might even be made from genome data.

Consensus sequence

Consensus sequence, from bioinformatics.oxfordjournals.org

Think of the possibilities for preventive medicine and crime prevention! With sufficient data, it would be straightforward to produce “Wanted”-style posters of people predisposed toward illness or indiscretion, enabling the appropriate authorities to step in and save both the public and the individuals themselves from suffering. 

There is a long-standing dialectic between the belief that individuality most faithfully expresses the real world and the belief that truth lies in averages–that variation is noise. Personalized medicine, which relies on “big data,” inches forward by the pushes and pulls of that dialectic, alternately claiming to tailor treatment to the individual and relying on racial categories considerably less differentiated than the composites above to parse disease and behavior.

The patron saint of this style of research is (or ought to be) a hybrid of Galton and Archibald Garrod, whose inborn errors of metabolism are often cited as the origin of the kind of individualized, biochemical-genetic approach so much in favor today. So we close with a portrait of that patron saint, Sir Francibald Galrod:

Galrod

Sir Francibald Galrod

*h/t Dmitry Pavluk

Print Friendly

Personalized placebo effect

A new article in Nature explores the placebo effect–therapeutic benefit from taking medicine without active ingredients. On the one hand, minimizing the placebo effect is a principle of ethical medical practice, a bulwark against hype, oversell, and charlatanism. Without controlling for therapeutic effects not caused by the drug, one may overestimate the drug’s potency. On the other hand, if the goal is to make the patient well, one might consider it ethical to use every option available—including whatever mysterious mechanisms the body can muster to augment the pharmaceutical therapy. The oldest tradition in medicine is that of helping the body heal itself.

Most interestingly, the placebo effect is highly individualized. This is not surprising, given the complex psycho-somatic interactions involved. Yet in an age in which personalized medicine is the idea of the moment, it seems essential to open the black box of the placebo effect. The authors summarize not only psychosocial variables known to influence patients’ responses to drugs—expectations, anxiety states, hypnosis, and so forth—but also a range of genetic and anatomical correlates of placebo responses. The strongest data are in the area of drugs for anxiety disorders and depression. Documented examples include polymorphisms in serotonin loci and in modulators of monoaminergic tone, plasma noradrenaline levels in interleukin-2 release, and brain anatomy in placebo analgesia.

Such data are exciting in historical as well as therapeutic context. In 1902, at the dawn of Mendelism, Archibald Garrod suggested that humans were as variable and individualized at the biochemical level as they are at the phenotypic level. If this were true, he continued, the phenomena of obesity, the various tints of hair, skin, and eyes, and “idiosyncrasies as regards drugs and the various degrees of natural immunity against infections” could be amenable to biochemical-genetic analysis.

Rufus of Ephesus

Rufus of Ephesus

Going further back, the Hippocratic physician Rufus of Ephesus noted that drugs act differently on different people, and that to prescribe appropriately the physician must ask the patients about their habits, their diet, preferences, sleep patterns, familial diseases, degrees of pain, and numerous other facets of the patient’s history and context. For the Hippocratic physician the body’s own powers of healing, mysterious though they be, were a crucial component of therapeutics. The Nature article’s abstract concludes with a nice statement of individuality that sounds like updated Hippocratism:

Personalizing placebo responses — which involves considering an individual’s genetic predisposition, personality, past medical history and treatment experience — could also maximize therapeutic outcomes.

Personalized medicine is often portrayed as a return to ancient Hippocratic ideals. It is and it isn’t. Despite the hype, “one-size-fits-all” medicine is too cost-effective to abandon. Personalized medicine has always been reserved for those who can pay for it, and little in the age of high-tech genomic medicine seems likely to change that. And yet, this attention to the unique constellation of essential and historical factors that combine in a given patient’s “irrational” drug response does bode well to be anodyne against some of the dehumanizing forces in the recent history of medicine.

 

Print Friendly

Sexuagenerian Double Helix

It’s not “DNA day.” That’s in April–fittingly, the date of publication. Today is double helix day.
On this date in 1953, Watson and Crick solved the structure of DNA. What better day to lay to rest a few myths about it?

Watson and Crick

Another, more candid shot from Barrington Brown’s roll.

1) It sparked a scientific revolution.
The double helix caused a stir in the scientific fields closest to Watson and Crick’s work: X-ray crystallography and bacteriophage genetics. But it took several years for the structure and it’s most important implication–the copying of the genetic material–to be confirmed. True, Time Magazine sent a photographer to Cambridge to shoot for a possible feature. From it came Barrington Brown’s famous photo of the duo before a mock-up of the structure, with Crick brandishing of all things a slide rule at it and smirking at the silliness, and Watson gazing, baffled, up at his hero. But they pulled the story. The double helix didn’t become world-famous until after the Nobel Prize, in 1962. the revolution did come, then, but it reverberated from the fusillade of discoveries from molecular biology of the fifties and early sixties: the double helix, the Meselson-Stahl experiment, the operon, and, perhaps most importantly, the genetic code.

Photograph 512. Watson stole Photograph 51.
The beautiful photograph of the diffraction pattern of b-form DNA taken by Rosalind Franklin and Raymond Gosling famously provided crucial evidence that enabled Watson and Crick to solve the structure. Watson obtained the image without Franklin’s knowledge. But the image was given by Gosling to Maurice Wilkins, who gave it to Watson. As correspondence recently published in The Annotated and Illustrated Double Helix makes clear, the administrative relationship between Wilkins and Franklin was murky. Franklin reasonably assumed she was independent of Wilkins; yet he apparently was technically if not in practice her supervisor. Watson may well have exploited these ambiguities; he was intensely competitive for that time. But theft is such an ugly word.

3. Watson and Crick were racing against Linus Pauling.
Pauling seems to have been genuinely surprised to learn that he was racing for the double helix against the oddball duo from Cambridge. Watson probably felt a sense of competition with the great pioneer of structural chemistry, but it takes two to race. Watson thought he was racing against everyone, with the possible exception of Crick. The real competition was with the group at King’s College London–Wilkins and Franklin.

4. The Double Helix is a history of the double helix.
Watson’s best-selling book is a literary-historical memoir. It is an important source for historians, but it must be read with care. The book was shaped by personal goals, politics, and literary strategies as much as by historical events. It is naive to treat it as a literal account of what “really happened.”

In the past sixty years, DNA has become the foundation of biomedicine, an emblem of innateness, the most famous molecule in history. It promises more revolutions to come, in healthcare and in our sense of identity. Let us celebrate it by demystifying it. History, too, can be salutary.

Read On

Comfort, Nathaniel. “‘Novel Features of Considerable Interest’.” Science 339, no. 6120 (2013): 648-48. doi:10.1126/science.1233356.

Gingras, Yves. “Revisiting the “Quiet Debut” of the Double Helix: A Bibliometric and Methodological Note on the “Impact” of Scientific Publications.” J Hist Biol 43, no. 1 (2010 2010): 159-81.

Creager, Angela N. H., and G. J. Morgan. “After the Double Helix: Rosalind Franklin’s Research on Tobacco Mosaic Virus.” Isis 99, no. 2 (2008 2008): 239-72.

de Chadarevian, Soraya. “Portrait of a Discovery : Watson, Crick, and the Double Helix.” Isis 94 (2003 2003): 90-105.

Print Friendly

Strike a blow for (and against) academic freedom

I am in favor of academic freedom. I am opposed to “academic freedom.” 

“America, meet the new creationism-in-sheep’s-clothing: The ‘academic freedom’ bill.” So begins Dana Liebelson on The Week, in an article on the latest version of the anti-science wedge being pushed into our schools. According to the National Center for Science Education, since 2004 more than 50 bills have been proposed that would require biology teachers to present conservative ideologies as science—in particular, the rejection of climate change and Intelligent Design (which I capitalize not to dignify it but to mark it as a dogma, distinct from engineering).

In the introduction to The Panda’s Black Box (Johns Hopkins, 2007), I traced the history of anti-Darwinist efforts and showed that they were getting simultaneously logically weaker and politically more potent. Each iteration, from the Scopes trial on down, has become more science-like and hence more insidious—harder to tell from the real thing. I wrote,

Thus, only vestiges of creationism remain in the public case for anti-Darwinism. On the current trajectory, one can easily imagine an anti-Darwinism so feeble that the Supreme Court cannot ban it. One must not forget that the so-called wedge strategy, the 1998 manifesto produced by the Discovery Institute’s Center for the Renewal of Science and Culture, is to make anti-Darwinism superficially indistinguishable from science, and thereby to gain access for more strongly theistic doctrines in the public schools. But this fact does not weaken the point: anti-Darwinism today is rhetorically formidable but intellectually anemic.

My point was that anti-science rhetoric has, ironically, become increasingly scientistic—ever more committed to the principle of explaining everything with science—including opposition to particular scientific findings. (Evolution, climate change, and gravity are all both findings and theories—the former in the sense that they are by now incontrovertible; the latter in the sense that they generate predictions and testable hypotheses.) This is their proponents’ strategy for insinuating crackpot ideologies into science classrooms, in order to undermine data they find ideologically inconvenient.

“Academic freedom” is just that kind of feebler anti-Darwinism (and anti-climate change) that I was talking about. Conservatives have appropriated a term that used to be a justification for tenure, mainly bandied around by tweedy academics in their cups at faculty dinner parties, and turned it into a wedge for intelligent design and struthian opposition to the fact that it is getting warmer, perhaps inexorably.

For now, academic freedom bills have not done well in state legislatures. The NCSE lists only two out of the 51 attempts as successful (Tennessee and Louisiana). But six such bills have already been proposed in 2013—more than in all of 2012—which suggests a ramping up of the effort.

I will say that I think that the climate change debate and anti-Darwinism in all its 31 flavors ought to be taught in school—but not in science class. They belong in the humanities curriculum, as part of an effort to teach the social context of science. Teaching this stuff as if it were science hamstrings good teachers by diverting precious class time from the real thing—which harms our students. However, there is no doubt that these are real controversies. They are social and cultural controversies that use science as their weapons. The existence of “academic freedom” bills is a potent argument for teaching our children not just a scientific approach to science but also a humanistic approach to science.

In social studies or a history of science or STS (science and technology studies) class, bring it on: let’s teach the controversy. But leave them out of science class, for chrissakes.

 

Print Friendly

Giving is Healthy

Kashkow logo3

 

Dear Valued Faculty Member:

It has been a challenging year for Kashkow Medicine. First, we completed the King Mullah Abdullah Medical Multiplex, the first healthcare resort to be attached to a major medical school. The KMAMM is a component of the Kaschkow International Strategy for Monetizing Yet Another Sector of Society (KISMYASS). Completing the KMAMM required purchasing one third of the land mass of our city, in addition to more than 20,000 sturdy cardboard boxes for relocating the residents who lived there. We are glad to report that the residents are enjoying the flexibility and simplicity of life in a cardboard box. That was only the beginning, of course. The twin 40-story towers of the KMAMM feature 5-bedroom luxury suites crafted to impress the most discriminating patient. Each suite comes with its own physical therapy facility, with pool, weight room, and ¼ mile indoor running track; a kitchen staffed by a gourmet chef; an occupational therapy facility, with potting studio and wood shop; a private staff of nurses; and sexual surrogates available on request, no questions asked. We designed these suites, in other words, to be like a home away from home for our most elite patients. The KMAMM also maintains three high-speed cruise ships, fitted with accommodations similar to the towers, that will make “house calls” anywhere in the world for patients who cannot come to Kashkow. We are entering an exciting age of personalized medicine. We understand that healthcare must be tailored to the unique needs of each individual. The most privileged patients, too, deserve to have their expectations accommodated, and meeting those demands is expensive.

Next, we received the news that an anonymous donor was giving us Chicago. Although this generous gift is an exciting opportunity, it comes with significant challenges. First, where will we put it? It is obviously in a bad location and besides, it is too far away. Further, maintaining a city of that size will require a major investment in infrastructure and staff. Nevertheless, with your help, we are confident that we can successfully extend the Kashkow brand to include this and other major metropolises around the world. Indeed, we are close to a deal on purchasing Greece, which is available for a song, comparatively speaking. But we can’t do it without you.

Dr. John Moneybags, the recently anointed Prince of Development at Kashkow, wishes to extend a special invitation to all faculty to be a part of these thrilling changes at our university by making a gift to the school. Although a recent article in Medical Money magazine ranks our School of Medicine faculty as among the lowest paid in American academic medicine, we remind you of the substantial fringe benefits we offer: a generous healthcare package including two free hospital stays of one night or less per year, partial tuition remission for one course per year in our Master’s program in Biomedical Business Administration, and a coupon for 5% off the full uninsured rate for a heart transplant (not to be used in combination with any other offer). These benefits amount to more than $105,000 in effective annual take-home pay. Seen in that light, our faculty are a significant resource to be tapped. In short, we value you and want to make more of you and from you.

We warmly thank all our faculty and staff for contributing to our Institutional Advancement Campaign by accepting a 10% involuntary pay cut for each of the next three years. But we think you can do more. We are asking, therefore, that you invest more of your salary by giving back to your institution through one of our many convenient giving opportunities. For those unable to commit to long-term support, a one-time gift of $1,000 will make a real difference in our inexorable rise to world domination in healthcare. The easiest option is an annual subscription of $5,000 per year, managed through our payroll deduction program (pretax!). These gifts will be acknowledged by a gold-tinted brick with your name laid in our “Walk of Fame,” which will connect Bank of America Hall to Saudi Arabia. Or consider our new “Life Member” program for junior faculty under the age of 35: pledge your firstborn child and receive a “Kashkow World” calendar, delivered to your door every year that you remain part of the Kashkow Family. Staff making less than $40,000 per year are encouraged to drop spare bills and pocket change in one of the many bright blue “I <3 KK” donation boxes conveniently located in every ward, laboratory, classroom, and meeting room on campus. They also accept MasterCard and Visa.

As the poet said, “Health is your most important asset.” It is certainly ours. Our “20×2020” campaign has set an ambitious goal of raising $20 trillion by the year 2020—which translates to roughly the amount of the national debt each year. We have never been willing to settle for “second best.” But we can’t do it without you, our third most important asset (after property). So please, dig deep and make your gift today. And again tomorrow.

Print Friendly